Impact of benralizumab on asthma control, asthma-related quality of life and lung function in patients with poorly controlled eosinophilic asthma: A systematic review and meta-analysis

2018 
AbstractBACKGROUND: Benralizumab is a monoclonal antibody to the alpha subunit of the IL-5 receptor used in the management of severe, eosinophilic asthma. Although Benralizumab has been shown to si...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    15
    References
    0
    Citations
    NaN
    KQI
    []